Showing results (6851-6860 of 25,889) with videos related to
Sort By:
Pageof 2,589
Anticancer Research|June 25, 2003
Adjuvant radiotherapy in locally confined prostate cancerUlrich Schäfer, Frank Witt, Oliver Micke, et al.Anticancer Research|June 25, 2003
Plasma levels of HER-2/neu, tumor type M2 pyruvate kinase and its tyrosine-phosphorylated metabolite in advanced breast cancerD Lüftner, S Mazurek, P Henschke, et al.Anticancer Research|June 25, 2003
HER-2/neu gene product in serum--an oncoprotein in the diagnosis and therapy of breast carcinomaGuntram SchulzeAnticancer Research|June 25, 2003
HER-2/neu determination in blood plasma of patients with HER-2/neu overexpressing metastasized breast cancer: a longitudinal studyMarkus Hoopmann, Rainer Neumann, Thérese Tanasale, et al.Anticancer Research|June 25, 2003
Prospective evaluation of tumor markers (c-erbB-2 oncoprotein, CEA and CA 15.3) in patients with locoregional breast cancerR Molina, X Filella, G Zanon, et al.Anticancer Research|June 25, 2003
Immunohistochemical expression of the tumour marker CA-125 in normal, hyperplastic and malignant endometrial tissueI Mylonas, J Makovitzky, D U Richter, et al.Anticancer Research|June 25, 2003
Stimulation of hCG protein and mRNA levels in trophoblast tumour cells Jeg3 and BeWo by glycodelin AClaudia Bergemann, Toralf Reimer, Heiner Müller, et al.Anticancer Research|June 25, 2003
Pre-analytical problems in the measurement of tumor type pyruvate kinase (tumor M2-PK)G M Oremek, F Gerstmeier, H Sauer-Eppel, et al.Anticancer Research|June 25, 2003
Soluble markers for the detection of hypoxia under antiangiogenic treatmentJoachim DrevsAnticancer Research|June 25, 2003
Single-cell irradiation from [211At] astatine-labeled C215 monoclonal antibody: improved estimates of radiosensitivity from measurements on cellular uptake and retentionStig Palm, Tom Bäck, Ingela Claesson, et al.Pageof 2,589